Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Providing Expert Treatment for all Urologic and Genitourinary Cancers
The doctors of the Stanford Urologic Cancer Program are dedicated to preserving quality of life and providing exceptional care through customized treatment plans for each patient. The program focuses on the investigation and management of cancers of the prostate, bladder, kidney, testis, and genitalia. Emphasis is placed on finding cancer treatments that take a multi-specialty approach to offer the greatest efficacy with the fewest complications.
Care and Treatment of Bladder, Kidney, Prostate, Urethra, and Testicular Cancers
Urologic Cancer Research at Stanford
Our team of urologic cancer experts at Stanford is actively engaged in performing novel research and designing innovative clinical trials for all types of urologic cancers, including bladder, kidney and prostate cancers.
Research highlights include:
Stem cell research aimed at developing new treatments
Improved molecular analysis of tumors to guide treatment decisions
Combination trials with targeted therapies, vaccine trials, and standard of care chemotherapies
Active bi-monthly seminars that highlight work of Stanford researchers and facilitate collaboration
Molecular profiling of kidney tumor tissue to develop biomarkers and better guide treatment
Combination trials with targeted therapies and traditional chemotherapies
New therapies that starve cancer cells of glucose
Advanced imaging studies and minimally invasive diagnostic technologies
Hedgehog signaling pathway discoveries that have led to development of novel therapies
Molecular analysis of prostate tumors that may enhance treatment decisions
Experimental anti-androgen hormone therapies that have recently been shown to increase patient survival
Quality of life studies, including urinary incontinence
Active surveillance studies: Evidence suggests that some low grade, early stage prostate cancers can be safely observed without treatment, so-called "active surveillance."
Check out this infographic that explains what you should know about prostate cancer.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Maps, directions, parking, public transit options, and contact information
Other patient resources
Please fax the Medical Record Release Form to your new patient coordinator. The medical release form is an authorization form for external facilities to release medical records to Stanford Health Care.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referring Physicians.
Fax a referral form with supporting documentation to 650-320-9443.
Please note, though this form is from Stanford Health Care, it is also used for all Cancer Center referrals.